These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1349444)

  • 1. Making sense of NSAID gastropathy and considering the therapeutic options.
    Agrawal NM
    Scand J Rheumatol Suppl; 1992; 92():13-9. PubMed ID: 1349444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatories and gastroduodenal damage: therapeutic options.
    Agrawal NM
    Eur J Rheumatol Inflamm; 1993; 13(1):17-24. PubMed ID: 7821335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Dube C; Wells G; Tugwell P; Welch V; Jolicoeur E; McGowan J
    Cochrane Database Syst Rev; 2002; (4):CD002296. PubMed ID: 12519573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of NSAID-induced gastroduodenal ulcers.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; (4):CD002296. PubMed ID: 11034748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs.
    Agrawal NM; Dajani EZ
    J Assoc Acad Minor Phys; 1992; 3(4):142-8. PubMed ID: 1392409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
    Raskin JB; White RH; Jackson JE; Weaver AL; Tindall EA; Lies RB; Stanton DS
    Ann Intern Med; 1995 Sep; 123(5):344-50. PubMed ID: 7625622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of NSAID induced gastroduodenal ulcers].
    Hansen JM; Bytzer P
    Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis and treatment of NSAID-induced gastroduodenal disorders.
    La Corte R; Caselli M; Castellino G; Bajocchi G; Trotta F
    Drug Saf; 1999 Jun; 20(6):527-43. PubMed ID: 10392669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of chronic NSAID induced upper gastrointestinal toxicity.
    Rostom A; Wells G; Tugwell P; Welch V; Dube C; McGowan J
    Cochrane Database Syst Rev; 2000; 2002(3):CD002296. PubMed ID: 10908548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.
    Hawkey CJ; Karrasch JA; Szczepañski L; Walker DG; Barkun A; Swannell AJ; Yeomans ND
    N Engl J Med; 1998 Mar; 338(11):727-34. PubMed ID: 9494149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of NSAIDs-induced gastropathy.
    La Corte R; Caselli M; Ruina M; Bajocchi G; Alvisi V; Trotta F
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():37-41. PubMed ID: 9032582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials.
    Leandro G; Pilotto A; Franceschi M; Bertin T; Lichino E; Di Mario F
    Dig Dis Sci; 2001 Sep; 46(9):1924-36. PubMed ID: 11575445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastro-duodenal protection in an era of cyclo-oxygenase-2-selective nonsteroidal anti-inflammatory drugs.
    Naesdal J; Wilson I
    Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1401-6. PubMed ID: 11742186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
    Agrawal NM; Dajani EZ
    J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.